News About: R&D
Donga ST announced that Marketing Authorization Application of superbacteria-target antibiotics ‘Tedizolid phosphate’ passed preliminary examination
On March 3, Donga ST announced that Marketing Authorization Application of superbacteria-target antibiotics ‘Tedizolid phosphate’ with indication of complicated Skin and Soft Tissue Infections, passed preliminary exam...
Ilyang Pharmaceutical company completed patient enrollment in Phase III clinical trial of Suepect
On Feb 26, Ilyang Pharmaceutical company (CEO Kim, Dong-Youn) announced that they has completed patient enrollment in Phase III clinical trials of leukemia treatment 'Supect (...
|
YungJin Pharmaceutical company received U.S. FDA acknowledge in the efficacy of COPD treatment on Phase 1 clinical trial
On Feb 21, YungJin Pharmaceutical company announced that they received U.S. FDA acknowledge in the efficacy of COPD (chronic obstructive pulmonary disease) treatment on Phase 1 clinical trial in the global natural dru...
Scientists develop new compound for treatment of obesity and diabetes
Korean scientists said Wednesday they have discovered a novel compound that may help treat obesity and diabetes, opening up the possibility of combating the chronic disease as a meaningful step forward and expands the...
Scientists found mechanism of acquired resistance to EGFR tyrosine kinase inhibitorsA group of scientists at Yonsei University have found a mechanism of acquired resistance to EGFR (epidermal growth factor receptor) tyrosine kinase inhibitors (TKI) in non–small...
|
DGIST, Agilent to set up neuroscience center
Daegu Gyeongbuk Institute of Science and Technology (DGIST), the government sponsoring institute, said Wednesday it a memorandum of understanding with the U.S. based Agilent Technologies to set up a national neuroscie...
14 stem cell clinical studies are underway
There are 14 stem cell clinical research projects currently underway by the nation’s leading bioengineering firms to develop commercial medications, according to the Korea Food and Drug Administration.
The administ...
US FDA approves phase 3 trial for new biological drug
Apimeds Inc., a local biopharmaceutical company, said it has received approval from the U.S. Food and Drug Administration to conduct Phase III clinical trial of a drug for the treatment of autoimmune disease and pain ...
Cytokine therapies: novel approaches for clinical indications
Despite outstanding therapeutic promise and sound scientific rationale, most cytokine therapies have largely failed to establish clinical utility.
Nevertheless, SIS Immunology Research Center said it is now aiming...
Sanofi-Pasteur Korea to launch DTaP-IPV combined vaccine
Sanofi-Pasteur Korea said it will release its DTaP-IPV combined vaccine “Tetraxim”, together with Handok pham.
The company said it has recently held a successful Tetraxim launching symposium at Grand Intercontinent...
